Intensive insulin therapy has evolved from multiple daily injections (MDI) to more advanced technological improvements that have been shown to decrease the chances of hypoglycemia and hyperglycemia, lessen fluctuations in blood sugar levels, and enhance the quality of life for patients [33]. This evidence concerns the gene INS and Hyperglycemia.